These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10766447)

  • 1. The antiangiogenesis effect of interleukin 12 during early growth of human pancreatic cancer in SCID mice.
    Sunamura M; Sun L; Lozonschi L; Duda DG; Kodama T; Matsumoto G; Shimamura H; Takeda K; Kobari M; Hamada H; Matsuno S
    Pancreas; 2000 Apr; 20(3):227-33. PubMed ID: 10766447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of interleukin-12 transfection on proliferation of ovarian cancer SKOV3 cells in vitro and in vivo].
    Wang J; Zhang CQ; Liu J; Sui LH
    Ai Zheng; 2007 Dec; 26(12):1292-8. PubMed ID: 18076789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.
    Duda DG; Sunamura M; Lozonschi L; Kodama T; Egawa S; Matsumoto G; Shimamura H; Shibuya K; Takeda K; Matsuno S
    Cancer Res; 2000 Feb; 60(4):1111-6. PubMed ID: 10706132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
    Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
    J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of angiogenesis in vivo by interleukin 12.
    Voest EE; Kenyon BM; O'Reilly MS; Truitt G; D'Amato RJ; Folkman J
    J Natl Cancer Inst; 1995 Apr; 87(8):581-6. PubMed ID: 7538593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
    Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
    Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
    Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer.
    Kundu N; Beaty TL; Jackson MJ; Fulton AM
    J Natl Cancer Inst; 1996 Apr; 88(8):536-41. PubMed ID: 8606382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis.
    Duda DG; Sunamura M; Lozonschi L; Yokoyama T; Yatsuoka T; Motoi F; Horii A; Tani K; Asano S; Nakamura Y; Matsuno S
    Br J Cancer; 2002 Feb; 86(3):490-6. PubMed ID: 11875720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngeneic immunocompetent mice.
    Sumimoto H; Tani K; Nakazaki Y; Tanabe T; Hibino H; Wu MS; Izawa K; Hamada H; Asano S
    Cancer Gene Ther; 1998; 5(1):29-37. PubMed ID: 9476964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12.
    Angiolillo AL; Sgadari C; Tosato G
    Ann N Y Acad Sci; 1996 Oct; 795():158-67. PubMed ID: 8958926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice.
    Orengo AM; Di Carlo E; Comes A; Fabbi M; Piazza T; Cilli M; Musiani P; Ferrini S
    J Immunol; 2003 Jul; 171(2):569-75. PubMed ID: 12847220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model.
    Zhang X; Galardi E; Duquette M; Delic M; Lawler J; Parangi S
    Clin Cancer Res; 2005 Mar; 11(6):2337-44. PubMed ID: 15788685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; PĂ©ron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model.
    Hess SD; Egilmez NK; Shiroko J; Bankert RB
    Cancer Gene Ther; 2001 May; 8(5):371-7. PubMed ID: 11477457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
    Trevino JG; Summy JM; Gray MJ; Nilsson MB; Lesslie DP; Baker CH; Gallick GE
    Cancer Res; 2005 Aug; 65(16):7214-22. PubMed ID: 16103072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells.
    Stangl S; Wortmann A; Guertler U; Multhoff G
    J Immunol; 2006 May; 176(10):6270-6. PubMed ID: 16670338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein.
    Shi Y; Parhar RS; Zou M; Baitei E; Kessie G; Farid NR; Alzahrani A; Al-Mohanna FA
    Hum Gene Ther; 2003 Dec; 14(18):1741-51. PubMed ID: 14670125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.